UAS regulatory sequences drive expression of a full-length Eip93F open reading frame (ORF) that is tagged at the C-terminal end with three copies of the Tag:HA epitope. The ORF is flanked by a pair of incompatible FRT sites (FRT5 and FRT2), which allows for future in vivo exchange of either the promoter or tag sequence.
Eip93FUAS.ORF.GW.Tag:HA, Scer\GAL4NP5130 is a suppressor of abnormal cell number | P-stage phenotype of EcRB1-ΔC655.F645A.UAS, Scer\GAL4NP5130
Eip93FUAS.ORF.GW.Tag:HA, Scer\GAL4NP5130 is a suppressor of abnormal cell number | P-stage phenotype of Scer\GAL4NP5130, uspHMS01620
Eip93FUAS.ORF.GW.Tag:HA, Scer\GAL4NP5130 is a suppressor of abnormal cell number | P-stage phenotype of Oatp74DRNAi.UAS.cUa, Scer\GAL4NP5130
Eip93FUAS.ORF.GW.Tag:HA, Scer\GAL4NP5130 is a suppressor of enteroendocrine cell | P-stage | decreased number phenotype of EcRB1-ΔC655.F645A.UAS, Scer\GAL4NP5130
Eip93FUAS.ORF.GW.Tag:HA, Scer\GAL4NP5130 is a suppressor of enteroendocrine cell | P-stage | decreased number phenotype of Scer\GAL4NP5130, uspHMS01620
Eip93FUAS.ORF.GW.Tag:HA, Scer\GAL4NP5130 is a suppressor of enteroendocrine cell | P-stage | decreased number phenotype of Oatp74DRNAi.UAS.cUa, Scer\GAL4NP5130